Company intelligence / Profile preview

Three Lakes Partners

Chicago, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Three Lakes Partners provides funding and operational support for projects improving diagnosis, treatment, and quality of life for IPF patients, such as the $1M IPF Catalyst Challenge (the largest Midwest healthcare prize as of 2017). No direct clinical trial results, as the company itself does not develop or test drugs.

Therapeutic areas: Pulmonology
Industry: Investors

Partnerships

MATTER (healthcare innovation hub)Pulmonary Fibrosis FoundationIDEO (design/innovation consulting)Common Pool (incentive program design)CHEST (American College of Chest Physicians)

Beyond the preview

Go deeper on Three Lakes Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Three Lakes Partners.

Explore the full profile